PROCEEDINGS VOLUME 8931
SPIE BIOS | 1-6 FEBRUARY 2014
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIII
Proceedings Volume 8931 is from: Logo
SPIE BIOS
1-6 February 2014
San Francisco, California, United States
Front Matter: Volume 8931
Proc. SPIE 8931, Front Matter: Volume 8931, 893101 (18 March 2014); doi: 10.1117/12.2053606
Photodynamic Therapy I
Proc. SPIE 8931, Increased efficacy of photodynamic therapy via sequential targeting, 893102 (14 April 2014); doi: 10.1117/12.2042421
Proc. SPIE 8931, Metal-based phthalocyanines as a potential photosensitizing agent in photodynamic therapy for the treatment of melanoma skin cancer, 893106 (14 April 2014); doi: 10.1117/12.2044382
Photodynamic Therapy II
Proc. SPIE 8931, Three-dimensional cell culturing by magnetic levitation for evaluating efficacy/toxicity of photodynamic therapy, 893109 (14 March 2014); doi: 10.1117/12.2040659
Proc. SPIE 8931, Evaluation of the Photodynamic Therapy effect using a tumor model in Chorioallantoic Membrane with Melanoma cells, 89310B (14 April 2014); doi: 10.1117/12.2040714
Photodynamic Therapy III
Proc. SPIE 8931, Development of image-guided targeted two-photon PDT for the treatment of head and neck cancers, 89310C (14 March 2014); doi: 10.1117/12.2043070
Proc. SPIE 8931, Noninvasive tumor oxygen imaging by photoacoustic lifetime imaging integrated with photodynamic therapy, 89310H (14 April 2014); doi: 10.1117/12.2040036
Photodynamic Therapy IV
Proc. SPIE 8931, Comparison of singlet oxygen threshold dose for PDT, 89310I (14 April 2014); doi: 10.1117/12.2039719
Proc. SPIE 8931, Recovery of optical properties from interstitial spectroscopy for photodynamic therapy treatment planning, 89310K (14 April 2014); doi: 10.1117/12.2037808
Photodynamic Therapy V
Proc. SPIE 8931, Photodynamic effect of photosensitizer-loaded hollow silica nanoparticles for hepatobiliary malignancies: an in vitro and in vivo study, 89310S (19 March 2014); doi: 10.1117/12.2039294
Proc. SPIE 8931, Photodynamic inactivation of pathogens causing infectious keratitis, 89310T (14 April 2014); doi: 10.1117/12.2037704
Photodynamic Therapy VI
Proc. SPIE 8931, Pulsed light imaging for wide-field dosimetry of photodynamic therapy in the skin, 89310W (14 March 2014); doi: 10.1117/12.2040174
Proc. SPIE 8931, Photodynamic therapy of cervical intraepithelial neoplasia, 89310X (14 March 2014); doi: 10.1117/12.2040004
Proc. SPIE 8931, Definitive surgery and intraoperative photodynamic therapy: A prospective study of local control and survival for patients with pleural dissemination of non-small cell lung cancer, 89310Y (14 April 2014); doi: 10.1117/12.2046679
Photodynamic Therapy VII
Proc. SPIE 8931, Porphyrin-based polysilsesquioxane nanoparticles to improve photodynamic therapy for cancer treatment, 89310Z (14 March 2014); doi: 10.1117/12.2039145
Proc. SPIE 8931, Diffuse optical tomography using multichannel robotic platform for interstitial PDT, 893110 (14 April 2014); doi: 10.1117/12.2040200
Photodynamic Therapy VIII
Proc. SPIE 8931, Investigation of dynamic morphological changes of cancer cells during photoimmuno therapy (PIT) by low-coherence quantitative phase microscopy, 893113 (14 April 2014); doi: 10.1117/12.2036944
Proc. SPIE 8931, ALA-PpIX variability quantitatively imaged in A431 epidermoid tumors using in vivo ultrasound fluorescence tomography and ex vivo assay, 893114 (14 March 2014); doi: 10.1117/12.2037800
Proc. SPIE 8931, In vitro studies of chlorin e6-assisted photodynamic inactivation of Helicobacter pylori, 893115 (14 March 2014); doi: 10.1117/12.2037769
Poster Session
Proc. SPIE 8931, Anisotropic modeling for IR navigation-based PDT dosimetry, 893118 (14 April 2014); doi: 10.1117/12.2039704
Proc. SPIE 8931, Comparison of PDT parameters for RIF and H460 tumor models during HPPH-mediated PDT, 89311C (14 April 2014); doi: 10.1117/12.2040241
Proc. SPIE 8931, Parameter determination for BPD mediated vascularPDT, 89311D (14 April 2014); doi: 10.1117/12.2040305
Back to Top